1. The role of interleukin-1β in pyoderma gangrenosum
Ricardo Luis Galimberti, PhD, MD, Aldana Soledad Vacas, MD, María Luz Bollea Garlatti, MD, Ana Clara Torre, MD 
JAAD Case Reports 
Volume 2, Issue 5, Pages (September 2016)
DOI: /j.jdcr
Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions

2. Fig 1
Evolution of the ulcer in inner left lower leg. A, Before treatment. B, Two weeks after the last doses of canakinumab. C, 6 months after the beginning of treatment.
JAAD Case Reports 2016 2, DOI: ( /j.jdcr )
Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions

3. Fig 2
Evolution of the ulcer in inner right lower leg. A, Before treatment. B, Two weeks after the last doses of canakinumab. C, None months after the beginning of treatment.
JAAD Case Reports 2016 2, DOI: ( /j.jdcr )
Copyright © 2016 American Academy of Dermatology, Inc. Terms and Conditions